Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.verified

ENSC

Price:

$0.5522

Market Cap:

$4.19M

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection agains...[Read more]

Industry

Biotechnology

IPO Date

2018-03-14

Stock Exchange

NASDAQ

Ticker

ENSC

The PE Ratio as of June 2024 (TTM) for Ensysce Biosciences, Inc. (ENSC) is -0.17

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.17. This represents a change of -50.76% compared to the average of -0.35 of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical PE Ratio (quarterly & annually)

How has ENSC PE Ratio performed in the past?

The mean historical PE Ratio of Ensysce Biosciences, Inc. over the last ten years is 945.83. The current -0.17 PE Ratio has changed -101.80% with respect to the historical average. Over the past ten years (40 quarters), ENSC's PE Ratio was at its highest in in the March 2018 quarter at 8.49K. The PE Ratio was at its lowest in in the June 2020 quarter at -65.53.

Quarterly (TTM)
Annual

Average

945.83

Median

-0.06

Minimum

-208.88

Maximum

6.67K

Ensysce Biosciences, Inc. (ENSC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual PE Ratio = 6.67K

Minimum Annual Increase = -225.50%

Minimum Annual PE Ratio = -208.88

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.23248.56%
2022-0.06-98.00%
2021-3.25-98.44%
2020-208.88-225.50%
2019166.45-97.50%
20186.67KInfinity%

Ensysce Biosciences, Inc. (ENSC) Average PE Ratio

How has ENSC PE Ratio performed in the past?

The current PE Ratio of Ensysce Biosciences, Inc. (ENSC) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.18

5-year avg

-9.20

10-year avg

945.83

Ensysce Biosciences, Inc. (ENSC) PE Ratio vs. Peers

How is ENSC’s PE Ratio compared to its peers?

Ensysce Biosciences, Inc.’s PE Ratio is greater than Zura Bio Limited (-3.08), greater than Phio Pharmaceuticals Corp. (-0.35), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.84), less than 180 Life Sciences Corp. (-0.06), greater than Cardio Diagnostics Holdings, Inc. (-1.01), greater than Virax Biolabs Group Limited (-0.44), greater than Blue Water Vaccines, Inc. (-0.17), greater than Revelation Biosciences, Inc. (-0.28), less than Hillstream BioPharma, Inc. (-0.00), less than Kiora Pharmaceuticals, Inc. (39.63), less than Quoin Pharmaceuticals, Ltd. (-0.15), less than Allarity Therapeutics, Inc. (-0.01), less than Kiromic BioPharma, Inc. (-0.15), less than Biodexa Pharmaceuticals Plc (-0.15), less than PaxMedica, Inc. Common Stock (-0.01),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ensysce Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ensysce Biosciences, Inc. (ENSC)?

What is the highest PE Ratio for Ensysce Biosciences, Inc. (ENSC)?

What is the 3-year average PE Ratio for Ensysce Biosciences, Inc. (ENSC)?

What is the 5-year average PE Ratio for Ensysce Biosciences, Inc. (ENSC)?

How does the current PE Ratio for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?